HK1205950A1 - 免疫耐受誘導劑 - Google Patents

免疫耐受誘導劑

Info

Publication number
HK1205950A1
HK1205950A1 HK15106630.6A HK15106630A HK1205950A1 HK 1205950 A1 HK1205950 A1 HK 1205950A1 HK 15106630 A HK15106630 A HK 15106630A HK 1205950 A1 HK1205950 A1 HK 1205950A1
Authority
HK
Hong Kong
Prior art keywords
immune tolerance
tolerance inducer
inducer
immune
tolerance
Prior art date
Application number
HK15106630.6A
Other languages
English (en)
Inventor
田中　徹
元夫 中島
史紀 安部
直實 芳賀
高橋　究
秀典 伊東
康 梨井
Original Assignee
Sbi Pharmaceuticals Co Ltd
Nat Ct For Child Health And Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbi Pharmaceuticals Co Ltd, Nat Ct For Child Health And Dev filed Critical Sbi Pharmaceuticals Co Ltd
Publication of HK1205950A1 publication Critical patent/HK1205950A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C12N5/064—Immunosuppressive dendritic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/05—Adjuvants
    • C12N2501/052—Lipopolysaccharides [LPS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2304—Interleukin-4 (IL-4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK15106630.6A 2012-07-13 2015-07-10 免疫耐受誘導劑 HK1205950A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012157374 2012-07-13
PCT/JP2013/004130 WO2014010206A1 (ja) 2012-07-13 2013-07-03 免疫寛容誘導剤

Publications (1)

Publication Number Publication Date
HK1205950A1 true HK1205950A1 (zh) 2015-12-31

Family

ID=49915689

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15104894.2A HK1204285A1 (zh) 2012-07-13 2015-05-22 免疫耐受誘導劑
HK15106630.6A HK1205950A1 (zh) 2012-07-13 2015-07-10 免疫耐受誘導劑

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15104894.2A HK1204285A1 (zh) 2012-07-13 2015-05-22 免疫耐受誘導劑

Country Status (9)

Country Link
US (1) US9399029B2 (zh)
EP (1) EP2873417B1 (zh)
JP (1) JP5904518B2 (zh)
CN (2) CN104411306B (zh)
HK (2) HK1204285A1 (zh)
HU (1) HUE043511T2 (zh)
PL (1) PL2873417T3 (zh)
TW (1) TWI619493B (zh)
WO (1) WO2014010206A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2767278B1 (en) * 2011-10-12 2019-11-06 SBI Pharmaceuticals Co., Ltd. Enhancer of survival of transplanted organ
EP2875813B1 (en) 2012-07-19 2018-04-18 SBI Pharmaceuticals Co., Ltd. Prophylactic/therapeutic agent for influenza virus infection
KR102492240B1 (ko) 2018-01-18 2023-01-27 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. 랑게린+ 세포 표적화
CN113181153B (zh) * 2021-05-31 2023-03-31 北京大学人民医院 柠檬酸在制备预防和/或治疗自身免疫病的药物中的应用
AU2023228176A1 (en) * 2022-03-01 2024-08-08 National Center For Child Health And Development Pharmaceutical composition for preventing and/or treating autoimmune diseases

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302431D0 (sv) 1993-07-16 1993-07-16 Ab Astra Use of indenoindole compounds
US5756492A (en) 1996-09-09 1998-05-26 Sangstat Medical Corporation Graft survival prolongation with porphyrins
JP4590041B2 (ja) 1998-12-24 2010-12-01 株式会社林原生物化学研究所 臓器保存剤
JP5230042B2 (ja) 1999-06-02 2013-07-10 株式会社ビーエムジー 動物の細胞または臓器の保存剤およびその保存方法。
CA2405806A1 (en) 2000-04-11 2001-10-18 University Of Southern California A method to prevent graft rejection using tgf-.beta. to induce t suppressor cells
JP2002060301A (ja) 2000-08-17 2002-02-26 Seikagaku Kogyo Co Ltd 臓器保存液
EP1439842A4 (en) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
US20040171601A1 (en) 2002-07-31 2004-09-02 Dai Fukumura Photodynamic and sonodynamic therapy
US20040235162A1 (en) 2003-03-18 2004-11-25 Kirin Beer Kabushiki Kaisha Method of preparing immunoregulatory dendritic cells and the use thereof
JP4547174B2 (ja) 2003-03-18 2010-09-22 協和発酵キリン株式会社 免疫制御性樹状細胞の調製法およびその用途
US20050032210A1 (en) 2003-03-18 2005-02-10 Kirin Beer Kabushiki Kaisha Method of preparing immuno-regulatory dendritic cells and the use thereof
JP2004300098A (ja) 2003-03-31 2004-10-28 Oxygenix:Kk 移植用臓器の処理方法
JP2005306749A (ja) 2004-04-19 2005-11-04 Kringle Pharma Inc Ｈｇｆ含有臓器保存液
JP4814567B2 (ja) 2004-09-02 2011-11-16 コスモ石油株式会社 健康機能向上剤
CA2579032C (en) 2004-09-02 2011-11-29 Cosmo Oil Co., Ltd. Use of an .delta.-amino acid as thymocyte growth agent
JP4814501B2 (ja) * 2004-09-02 2011-11-16 コスモ石油株式会社 抗酸化機能向上剤
JP4919453B2 (ja) 2005-04-07 2012-04-18 独立行政法人理化学研究所 炎症性疾患の予防又は治療剤
MX2007013623A (es) * 2005-04-28 2008-02-12 Cosmo Oil Co Ltd Preparacion externa para la piel.
JP2006316000A (ja) 2005-05-12 2006-11-24 Vitamin C60 Bioresearch Kk 血液または臓器の保存剤と保存方法
JP2007131598A (ja) 2005-11-14 2007-05-31 Kurosu Biotech:Kk 腎移植拒絶反応抑制剤
WO2007100154A1 (ja) * 2006-03-03 2007-09-07 Riken アレルギー疾患に対する制御性樹状細胞を用いた免疫細胞療法
JP5150091B2 (ja) 2006-11-01 2013-02-20 日本澱粉工業株式会社 低酸素状態下での細胞及び心臓保存剤
WO2009073599A1 (en) 2007-11-30 2009-06-11 Therakos, Inc. Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells
JP2009221128A (ja) 2008-03-14 2009-10-01 Seizo Fujikawa 臓器保存液および臓器保存方法
CN102014890B (zh) * 2008-05-14 2015-08-05 思佰益药业股份有限公司 男性不育治疗剂
CA2728423A1 (en) 2008-06-06 2009-12-10 Baylor Research Institute Respiratory syncytial virus renders dendritic cells tolerogenic
JP5295652B2 (ja) 2008-06-16 2013-09-18 Ｓｂｉファーマ株式会社 光障害の軽減剤
CN102164596A (zh) * 2008-10-27 2011-08-24 Sbi5-Ala生物技术股份有限公司 以5-氨基乙酰丙酸或其衍生物、或它们的盐作为有效成分的成人病的预防、改善剂
JP2009143939A (ja) * 2009-01-27 2009-07-02 Tsujido Chemical Corp 治療剤
JP5611548B2 (ja) 2009-07-08 2014-10-22 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
WO2011048766A1 (ja) 2009-10-21 2011-04-28 国立大学法人愛媛大学 自己免疫疾患治療に用いる新規抗原としての炭酸脱水酵素ｉ
KR20120135265A (ko) 2010-02-23 2012-12-12 내셔널 유니버시티 코포레이션 홋카이도 유니버시티 제어성 수상세포의 작제방법
KR101723834B1 (ko) 2010-05-19 2017-04-06 에스비아이 파마 가부시키가이샤 ５-아미노레불린산 또는 그 유도체를 유효성분으로 하는 항말라리아약
EP2722041B1 (en) 2011-06-16 2018-10-24 SBI Pharmaceuticals Co., Ltd. Therapeutic agent for allergic rhinitis
EP2767278B1 (en) 2011-10-12 2019-11-06 SBI Pharmaceuticals Co., Ltd. Enhancer of survival of transplanted organ
JP5369206B2 (ja) * 2012-03-08 2013-12-18 コスモ石油株式会社 ５−アミノレブリン酸塩酸塩の製造方法

Also Published As

Publication number Publication date
TWI619493B (zh) 2018-04-01
HUE043511T2 (hu) 2019-08-28
HK1204285A1 (zh) 2015-11-13
CN106474098B (zh) 2020-06-05
CN106474098A (zh) 2017-03-08
US9399029B2 (en) 2016-07-26
US20150174090A1 (en) 2015-06-25
JPWO2014010206A1 (ja) 2016-06-20
CN104411306A (zh) 2015-03-11
EP2873417A4 (en) 2016-03-09
WO2014010206A1 (ja) 2014-01-16
EP2873417B1 (en) 2019-03-06
EP2873417A1 (en) 2015-05-20
TW201408285A (zh) 2014-03-01
PL2873417T3 (pl) 2019-09-30
CN104411306B (zh) 2017-05-24
JP5904518B2 (ja) 2016-04-13

Similar Documents

Publication Publication Date Title
HK1213791A1 (zh) 免疫應答的增强
EP2834762A4 (en) SEQUENCE ASSEMBLY
HK1205512A1 (zh) 氨基取代的咪唑並噠嗪
EP2920087A4 (en) CHILDREN'S PUMPS
GB2505469B (en) Connection assembly
PL2805380T3 (pl) Element łączący
CO6841993A2 (es) Inducción de tolerancia inmunológica utilizando metotrexato
PL2637476T3 (pl) Płyta kuchenna
GB201202255D0 (en) Pumps
EP2938160A4 (en) RANGE
HK1205950A1 (zh) 免疫耐受誘導劑
HK1219436A1 (zh) 免疫調節
EP2806169A4 (en) INDUCTOR
ZA201503966B (en) Immune-tolerance inducer
EP2742944A4 (en) immunotolerance
PL2852614T3 (pl) Szczepionka oparta na składniku dopełniacza - C5A
GB2507307B (en) Impeller
SG11201406556SA (en) Heat pump
KR101334557B9 (ko) 조리용기
EP2850426A4 (en) CONNECTION ARRANGEMENT
HK1197313A1 (zh) 感應組件
GB201204751D0 (en) Immune modulation
EP2811231A4 (en) COOKER
GB201221097D0 (en) Heat pump
IL238547A0 (en) Immune tolerance inducer

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210705